OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
HPV-induced cancers: preclinical therapeutic advancements
Lorenzo Messa, Arianna Loregian
Expert Opinion on Investigational Drugs (2021) Vol. 31, Iss. 1, pp. 79-93
Open Access | Times Cited: 9
Lorenzo Messa, Arianna Loregian
Expert Opinion on Investigational Drugs (2021) Vol. 31, Iss. 1, pp. 79-93
Open Access | Times Cited: 9
Showing 9 citing articles:
Human papillomavirus in the setting of immunodeficiency: Pathogenesis and the emergence of next-generation therapies to reduce the high associated cancer risk
Rehana Hewavisenti, Joshua Arena, Chantelle Ahlenstiel, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 58
Rehana Hewavisenti, Joshua Arena, Chantelle Ahlenstiel, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 58
Role of infectious agents in Cancer pathogenesis and therapy
Ezichi F. Ofoezie, C Ogbonna, Sandra C. Olisakwe, et al.
The Microbe (2025), pp. 100284-100284
Open Access
Ezichi F. Ofoezie, C Ogbonna, Sandra C. Olisakwe, et al.
The Microbe (2025), pp. 100284-100284
Open Access
VIPER-TACs leverage viral E3 ligases for disease-specific targeted protein degradation
Kyle Mangano, Robert G. Guenette, Spencer Hill, et al.
Cell chemical biology (2025)
Open Access
Kyle Mangano, Robert G. Guenette, Spencer Hill, et al.
Cell chemical biology (2025)
Open Access
A small molecule targeting the interaction between human papillomavirus E7 oncoprotein and cellular phosphatase PTPN14 exerts antitumoral activity in cervical cancer cells
Chiara Bertagnin, Lorenzo Messa, Matteo Pavan, et al.
Cancer Letters (2023) Vol. 571, pp. 216331-216331
Open Access | Times Cited: 9
Chiara Bertagnin, Lorenzo Messa, Matteo Pavan, et al.
Cancer Letters (2023) Vol. 571, pp. 216331-216331
Open Access | Times Cited: 9
Targeted Disruption of E6/p53 Binding Exerts Broad Activity and Synergism with Paclitaxel and Topotecan against HPV-Transformed Cancer Cells
Marta Celegato, Lorenzo Messa, Chiara Bertagnin, et al.
Cancers (2021) Vol. 14, Iss. 1, pp. 193-193
Open Access | Times Cited: 11
Marta Celegato, Lorenzo Messa, Chiara Bertagnin, et al.
Cancers (2021) Vol. 14, Iss. 1, pp. 193-193
Open Access | Times Cited: 11
VIPER-TACs leverage viral E3 ligases for disease-specific targeted protein degradation
Kyle Mangano, Robert G. Guenette, Spencer Hill, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Kyle Mangano, Robert G. Guenette, Spencer Hill, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Nanotherapy for human papillomavirus-associated cancers: breakthroughs and challenges
Jéssica Lopes‐Nunes, Paula A. Oliveira, Carla Cruz
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 9, pp. 781-797
Closed Access
Jéssica Lopes‐Nunes, Paula A. Oliveira, Carla Cruz
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 9, pp. 781-797
Closed Access
Small Molecule Inhibitors of Human Papillomavirus: A Review of Research from 1997 to 2021
Caitlin L. Duncan, Hendra Gunosewoyo, Mauro Mocerino, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 33, pp. 5308-5350
Closed Access | Times Cited: 1
Caitlin L. Duncan, Hendra Gunosewoyo, Mauro Mocerino, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 33, pp. 5308-5350
Closed Access | Times Cited: 1
